| Literature DB >> 17505530 |
Vinod K Sharma1, Shipra Srivastava, Ankita Srivastava.
Abstract
The synthetic, spectroscopic, and biological studies of sixteen ring-substituted 4-phenylthiosemicarbazones andEntities:
Year: 2007 PMID: 17505530 PMCID: PMC1852900 DOI: 10.1155/2007/68374
Source DB: PubMed Journal: Bioinorg Chem Appl Impact factor: 7.778
Figure 1Structure of the thiosemicarbazone ligands.
Analytical data for the ligands and their Ru(III) and Rh(III) complexes.
| Compounds | M. wt. found (calcd.) | Yield (%) | Color | Analysis: found (calcd.)% |
| |||||
|
| ||||||||||
| C | H | N | Cl/F | S | M | |||||
|
| ||||||||||
| HAPT | 285 | 70 | Pale yellow | 63.0 | 5.0 | 14.2 | — | 11.0 | — | — |
| (285) | (63.1) | (5.2) | (14.7) | (11.2) | ||||||
| HANPT | 328 | 72 | Yellow brown | 54.3 | 3.9 | 16.2 | — | 9.5 | — | — |
| (330) | (54.5) | (4.2) | (16.9) | (9.6) | ||||||
| HCBPT | 288 | 70 | Cream yellow | 57.8 | 3.9 | 14.0 | 12.0 | 11.0 | — | — |
| (289) | (58.1) | (4.1) | (14.5) | (12.1) | (11.0) | |||||
| HCBNPT | 332 | 75 | Yellow | 49.0 | 3.0 | 16.2 | 10.0 | 9.3 | — | — |
| (334) | (50.2) | (3.2) | (16.7) | (10.4) | (9.5) | |||||
| HFBPT | 271 | 74 | Yellow | 61.0 | 4.0 | 15.0 | 6.2 | 11.4 | — | — |
| (273) | (61.4) | (4.3) | (15.3) | (6.9) | (11.7) | |||||
| HFBNPT | 317 | 75 | Yellow | 52.6 | 3.0 | 17.2 | 5.4 | 10.0 | — | — |
| (318) | (52.8) | (3.4) | (17.6) | (5.9) | (10.0) | |||||
| HVPT | 300 | 75 | Yellow brown | 59.1 | 4.7 | 13.8 | — | 10.4 | — | — |
| (301) | (59.7) | (4.9) | (13.9) | (10.6) | ||||||
| HVNPT | 345 | 75 | Yellow | 51.5 | 3.8 | 15.9 | — | 9.2 | — | — |
| (346) | (51.9) | (4.0) | (16.1) | (9.2) | ||||||
|
| 1062 | 68 | Greenish brown | 50.2 | 3.9 | 11.6 |
| 9.0 | 9.2 | 1.08 |
| (1063) | (50.7) |
| (11.8) | (9.8) | (9.0) | (9.5) | ||||
|
| 1196 | 60 | Black | 44.9 | 3.2 | 13.8 | 8.5 | 8.0 | 8.2 | 1.88 |
| (1197) | (45.0) | (3.5) | (14.0) | (8.7) | (7.9) | (8.4) | ||||
|
| 1075 | 60 | Brown | 46.4 | 3.0 | 11.2 | 19.3 | 8.9 | 9.0 | 1.89 |
| (1076) | (46.8) | (3.3) | (11.7) | (19.5) | (8.6) | (9.3) | ||||
|
| 1210 | 62 | Black | 41.3 | 2.5 | 13.2 | 17.1 | 7.9 | 8.0 | 1.78 |
| (1205) | (41.6) | (2.7) | (13.8) | (17.3) | (7.6) | (8.3) | ||||
|
| 1026 | 60 | Dark brown | 48.0 | 2.6 | 12.0 | 10.0 | 9.3 | 9.2 | 1.80 |
| (1027) | (49.1) | (3.5) | (12.2) | (10.2) | (9.3) | (9.8) | ||||
|
| 1160 | 60 | Black | 43.1 | 2.6 | 14.2 | 8.8 | 8.2 | 8.4 | 1.90 |
| (1162) | (43.4) | (2.8) | (14.4) | (9.0) | (8.0) | (8.6) | ||||
|
| 1110 | 60 | Brown | 48.2 | 3.7 | 11.1 | 9.2 | 8.6 | 8.9 | 1.68 |
| (1111) | (48.6) | (4.0) | (11.3) | (9.4) | (8.5) | (9.0) | ||||
|
| 1243 | 65 | Black | 43.0 | 3.1 | 13.2 | 8.2 | 7.7 | 7.9 | 1.70 |
| (1245) | (43.3) | (3.3) | (13.4) | (8.4) | (7.2) | (8.1) | ||||
|
| 1063 | 70 | Orange brown | 50.2 | 3.9 | 11.2 | 9.4 | 9.0 | 9.0 | — |
| (1065) | (50.7) | (4.2) | (11.8) | (9.8) | (8.9) | (9.5) | ||||
|
| 1196 | 65 | Maroon | 44.8 | 3.3 | 13.9 | 8.5 | 8.0 | 8.2 | — |
| (1198) | (45.0) | (3.5) | (14.0) | (8.7) | (8.0) | (8.5) | ||||
|
| 1076 | 60 | Brown | 46.5 | 3.0 | 11.2 | 19.2 | 8.9 | 9.3 | — |
| (1077) | (46.7) | (3.3) | (11.6) | (19.4) | (8.4) | (9.5) | ||||
|
| 1211 | 65 | Brown | 41.2 | 2.4 | 13.3 | 17.1 | 7.9 | 8.2 | — |
| (1213) | (41.5) | (2.7) | (13.8) | (17.3) | (7.4) | (8.4) | ||||
|
| 1028 | 62 | Rusty brown | 48.9 | 3.1 | 11.8 | 10.0 | 9.3 | 9.8 | — |
| (1028) | (49.0) | (3.5) | (12.2) | (10.2) |
| (10.0) | ||||
|
| 1162 | 62 | Brown | 43.1 | 2.6 | 14.3 | 8.9 | 8.2 | 8.6 | — |
| (1163) | (43.3) | (2.8) | (14.4) | (9.0) | (8.1) | (8.7) | ||||
|
| 1112 | 60 | Maroon | 48.4 | 3.9 | 11.2 | 9.3 | 8.6 | 9.0 | — |
| (1113) | (48.5) | (4.0) | (11.3) | (9.4) | (8.3) | (9.1) | ||||
|
| 1244 | 68 | Blackish brown | 43.1 | 3.2 | 13.2 | 8.2 | 7.7 | 8.0 | — |
| (1245) | (43.3) | (3.3) | (13.4) | (8.4) | (7.2) | (8.1) | ||||
Figure 2Suggested structure of the complexes.
Infrared spectral data (cm−1) of the ligands and its complexes. s = strong, m = medium, w = weak.
| Compounds | Assignments | |||||
|
| ||||||
|
|
|
|
|
|
| |
|
| ||||||
| HAPT | 2831 s | 1030 m | 1594 s | 827 s | — | — |
| HANPT | 2832 s | 1022 m | 1600 s | 860 s | — | — |
| HCBPT | 2830 s | 1020 m | 1594 s | 862 s | — | — |
| HCBNPT | 2835 s | 1028 m | 1595 s | 872 s | — | — |
| HFBPT | 2840 s | 1030 m | 1610 s | 830 s | — | — |
| HFBNPT | 2835 s | 1020 m | 1595 s | 870 s | — | — |
| HVPT | 2842 s | 1026 m | 1605 s | 860 s | — | — |
| HVNPT | 2840 s | 1022 m | 1610 s | 830 s | — | — |
|
| 2831 s | 1036 m | 1580 s | 820 s | 520 m | 440 s |
|
| 2831 s | 1030 m | 1590 s | 850 s | 560 m | 460 s |
|
| 2830 s | 1030 m | 1585 s | 852 s | 535 s | 400 s |
|
| 2834 m | 1035 m | 1580 s | 860 s | 520 m | 430 s |
|
| 2841 m | 1040 m | 1600 s | 820 s | 525 w | 410 m |
|
| 2835 s | 1025 m | 1585 m | 860 s | 530 m | 450 m |
|
| 2842 s | 1032 m | 1590 m | 850 s | 545 m | 430 m |
|
| 2841 s | 1033 m | 1600 s | 820 s | 560 m | 435 s |
|
| 2830 m | 1035 m | 1580 s | 820 s | 520 m | 430 w |
|
| 2832 s | 1032 m | 1589 m | 840 s | 530 w | 450 w |
|
| 2831 m | 1032 m | 1580 s | 850 s | 540 w | 445 w |
|
| 2836 s | 1035 m | 1585 s | 855 s | 560 w | 418 m |
|
| 2841 s | 1038 m | 1600 s | 820s | 545 m | 415 m |
|
| 2835 w | 1028 m | 1580 s | 860 s | 542 m | 425 s |
|
| 2842 s | 1036 m | 1592 m | 845 s | 535 m | 435 s |
|
| 2841 s | 1030 m | 1598 s | 820 s | 532 m | 440 m |
Electronic spectral bands (cm−1) and ligand field parameters of the Ru(III) and Rh(III) complexes.
| Complex |
| Assignments |
| 10 Dq (cm−1) | B (cm−1) | C (cm−1) |
|
|
| |||||||
|
| 13700 |
2 T2g → 4 T1g ( | 1.25 | 27342 | 443 | 2858 | 0.70 |
| 17240 |
2 T2g → 4 T2g ( | ||||||
| 23600 |
2 T2g → 2 A2g, 2 T1g ( | ||||||
|
| |||||||
|
| 13500 | -do- | 1.27 | 27383 | 470 | 2883 | 0.75 |
| 17260 | |||||||
| 23560 | |||||||
|
| |||||||
|
| 14060 | -do- | 1.27 | 27255 | 475 | 2705 | 0.76 |
| 17860 | |||||||
| 23600 | |||||||
|
| |||||||
|
| 13520 | -do- | 1.28 | 27352 | 474 | 2866 | 0.75 |
| 17310 | |||||||
| 23540 | |||||||
|
| |||||||
|
| 13620 | -do- | 1.31 | 27277 | 539 | 2741 | 0.86 |
| 17930 | |||||||
| 23460 | |||||||
|
| |||||||
|
| 14000 | -do- | 1.30 | 27309 | 538 | 2656 | 0.86 |
| 18300 | |||||||
| 23580 | |||||||
|
| |||||||
|
| 13510 | -do- | 1.33 | 27795 | 565 | 2865 | 0.90 |
| 18030 | |||||||
| 23800 | |||||||
|
| |||||||
|
| 14060 | -do- | 1.29 | 26875 | 523 | 2551 | 0.83 |
| 18240 | |||||||
| 23280 | |||||||
|
| |||||||
|
| 17600 | 1 A1g → 3 T1g | 1.34 | 21950 | 435 | 1740 | 0.60 |
| 20210 |
1 A1g → 1 T1g ( | ||||||
| 27170 |
1 A1g → 1 T2g ( | ||||||
|
| |||||||
|
| 17550 | -do- | 1.35 | 22060 | 445 | 1780 | 0.62 |
| 20280 | |||||||
| 27400 | |||||||
|
| |||||||
|
| 17260 | -do- | 1.32 | 22615 | 413 | 1655 | 0.57 |
| 20960 | |||||||
| 27580 | |||||||
|
| |||||||
|
| 17300 | -do- | 1.35 | 21990 | 442 | 1770 | 0.61 |
| 20220 | |||||||
| 27300 | |||||||
|
| |||||||
|
| 17400 | -do- | 1.37 | 22290 | 478 | 1910 | 0.66 |
| 20380 | |||||||
| 28020 | |||||||
|
| |||||||
|
| 17640 | -do- | 1.37 | 22815 | 481 | 1925 | 0.67 |
| 20890 | |||||||
| 28590 | |||||||
|
| |||||||
|
| 17650 | -do- | 1.32 | 22618 | 414 | 1658 | 0.58 |
| 20960 | |||||||
| 27590 | |||||||
|
| |||||||
|
| 17460 | -do- | 1.34 | 22655 | 444 | 1775 | 0.62 |
| 20880 | |||||||
| 27980 | |||||||
NMR spectral data (δ, ppm) of the thiosemicarbazones and their rhodium(III) complexes.
| Compounds | 1H− | 13C− | |||||
|
| |||||||
|
|
|
|
|
|
|
| |
|
| |||||||
| HAPT | 8.02 (s) | 10.9 (s) | 6.2–7.0 (m) | 3.62 (s) | 162.3 | 179.2 | 65.0 |
| HANPT | 8.06 (s) | 11.0 (s) | 6.2–7.8 (m) | 3.65 (s) | 162.6 | 179.6 | 65.2 |
| HCBPT | 8.08 (s) | 11.0 (s) | 6.2–7.6 (m) | — | 163.2 | 180.0 | — |
| HCBNPT | 8.06 (s) | 11.2 (s) | 6.2–7.8 (m) | — | 163.8 | 180.3 | — |
| HFBPT | 9.00 (s) | 10.9 (s) | 6.3–7.2 (m) | — | 165.0 | 179.8 | — |
| HFBNPT | 9.02 (s) | 11.1 (s) | 6.6–8.0 (m) | — | 165.2 | 180.2 | — |
| HVPT | 9.02 (s) | 11.0 (s) | 6.8–8.0 (m) | 3.60 (s) | 164.2 | 179.5 | 65.0 |
| HVNPT | 8.08 (s) | 11.2 (s) | 6.2–7.8 (m) | 3.61 (s) | 163.9 | 180.2 | 65.2 |
|
| 8.20 (s) | 10.6 (s) | 6.4–7.2 (m) | 3.65 (s) | 160.5 | 171.9 | 65.5 |
|
| 8.28 (s) | 10.9 (s) | 6.5–7.6 (m) | 3.66 (s) | 160.8 | 172.2 | 65.5 |
|
| 8.26 (s) | 11.1 (s) | 6.6–7.9 (m) | — | 162.0 | 172.6 | — |
|
| 9.20 (s) | 11.0 (s) | 6.8–8.2 (m) | — | 162.6 | 172.8 | — |
|
| 9.18 (s) | 10.9 (s) | 6.9–8.0 (m) | — | 163.0 | 172.6 | — |
|
| 9.20 (s) | 11.0 (s) | 6.6–8.0 (m) | — | 163.0 | 172.8 | — |
|
| 9.16 (s) | 11.2 (s) | 6.9–7.2 (m) | 3.62 (s) | 161.6 | 172.3 | 65.6 |
|
| 8.20 (s) | 11.0 (s) | 6.4–7.8 (m) | 3.61 (s) | 161.2 | 172.8 | 65.6 |
Antibacterial screening data of thiosemicarbazones and their Ru(III) and Rh(III) complexes.
| Compounds | Inhibition zone
( | |||
|
| ||||
| Bacillus subtilis | Pseudomonos aeruginosa | |||
|
| ||||
| 500 | 1000 | 500 | 1000 | |
|
| ||||
| HAPT | 7 | 9 | 8 | 9 |
|
| 14 | 17 | 13 | 16 |
|
| 10 | 12 | 9 | 12 |
| HANPT | 7 | 10 | 7 | 11 |
|
| 12 | 16 | 11 | 16 |
|
| 10 | 14 | 10 | 13 |
| HCBPT | 6 | 10 | 6 | 9 |
|
| 13 | 16 | 12 | 16 |
|
| 11 | 16 | 11 | 14 |
| HCBNPT | 7 | 10 | 7 | 11 |
|
| 14 | 18 | 15 | 19 |
|
| 12 | 14 | 13 | 15 |
| HFBPT | 7 | 9 | 6 | 10 |
|
| 13 | 16 | 13 | 17 |
|
| 10 | 13 | 10 | 12 |
| HFBNPT | 6 | 10 | 6 | 9 |
|
| 14 | 17 | 13 | 16 |
|
| 11 | 14 | 11 | 15 |
| HVPT | 9 | 12 | 9 | 11 |
|
| 14 | 17 | 14 | 16 |
|
| 11 | 14 | 11 | 13 |
| HVNPT | 8 | 10 | 9 | 11 |
|
| 15 | 18 | 14 | 18 |
|
| 12 | 15 | 12 | 14 |
| Streptomycin | 17 | 18 | 21 | 22 |